B

Billionbrains

Q1 FY27Capital Markets

Billionbrains Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹203
Market cap₹1.2L Cr
P/E50.7
Updated25 Aug 2026
Read4 min read

What the Q1 FY27 call signalled

2 of 3 strong

RevenueGood growth
MarginMargins steady
CapexCapex planned

The short version

Strong product pipeline over the next 1-2 years with significant launches including "W" (a large product suite for affluent and HNI customers), bonds (launched last quarter with strong uptake), and U.S. Management indicates a consistent focus on improving user experience and launching new products, underpinning long-term growth.

From Billionbrains's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Good growth
  • Strong product pipeline over the next 1-2 years with significant launches including "W" (a large product suite for affluent and HNI customers), bonds (launched last quarter with strong uptake), and U.S. stocks (upcoming launch).
  • Focus on continuous improvement and iteration of existing products to enhance customer experience and increase engagement.
  • Confident in sustained growth driven by better product-market fit and demand assessment before launches.
  • Expansion into wealth management with AI-driven personalized services expected to enhance customer retention and monetization.
  • Anticipated increase in multi-product adoption on the platform, strengthening overall revenues.
  • Retention of affluent customers is very high (~almost 100%), supporting stable revenue from high-value clients.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Billionbrains said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • The company is focused on building and launching new products such as W (a comprehensive product suite for affluent and HNI customers), bonds, and US stocks through the GIFT City route, indicating strategic investments in product expansion.
  • There is a strong pipeline for product launches over the next 1-2 years, with continuous improvements planned for existing products.
  • Investment is directed towards enhancing AI capabilities for better customer experience and product innovation.

2 more points management made on capital expenditure plans

Top-ranked in Capital Markets

Ranked on what management guided this quarter

5x potential
1BSE
Rev 2Mar 3
2Nippon Life Ind.
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Billionbrains said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided does not explicitly mention the current or expected orderbook or pending orders for Billionbrains Garage Ventures Limited (Groww). However, relevant information related to business activities and product pipeline includes: - Strong product pipeline for the next 1-2 years, including mammoth product "W" targeting affluent and HNI customers. - Bonds launched last quarter showing strong uptick and positive market response. - Upcoming launch of U.S. stocks product tied to recent regulatory developments. - Continued growth focus on MTF (Margin Trading Facility) with increasing ticket sizes and product improvements.

2 more points management made on order book & pipeline

Billionbrains — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.5K Cr, net profit ₹686 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Billionbrains Garage Ventures Ltd's management said in earlier quarters

Others in Capital Markets this season

  • CARE Ratings Ltd (Q1 FY27)

    111.68 Cr, up 18.9% YoY (Page 2, 13) . Key concall takeaways from CARE Ratings Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • ICRA Ltd (Q1 FY27)

    Revenue for Q1 FY2027: INR 163.4 crore, up from INR 124.5 crore in Q1 FY2026 (31.2% YoY growth). Key concall takeaways from ICRA Ltd's Q1 FY27 earnings call…

  • Emkay Global Financial Services Ltd (Q1 FY27)

    Consolidated revenue for Q1 FY27: INR 965 million, up 24% YoY (Page 9, 10, 27) . Key concall takeaways from Emkay Global Financial Services Ltd's Q1 FY27…

  • Systematix Corporate Services Ltd (Q1 FY27)

    Q1 FY27 consolidated total income from operations was ₹56.26 Cr (Page 12), compared to ₹39.17 Cr in Q1 FY26 (Page 11), indicating a significant year-on-year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Billionbrains Q1 FY27 results?

Strong product pipeline over the next 1-2 years with significant launches including "W" (a large product suite for affluent and HNI customers), bonds (launched last quarter with strong uptake), and U.S. Management indicates a consistent focus on improving user experience and launching new products, underpinning long-term growth.

What is Billionbrains share price analysis?

Billionbrains currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 50.7 with a market cap of ₹123,596 Cr. Investors should review the full earnings analysis for detailed insights.

Is Billionbrains planning capital expenditure?

The company is focused on building and launching new products such as W (a comprehensive product suite for affluent and HNI customers), bonds, and US stocks through the GIFT City route, indicating strategic investments in product expansion.

Keep Billionbrains on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.